Leukocyte-Independent Effects of CC-Chemokines on Vascular Remodeling

Author(s): Sara Paccosi*, Astrid Parenti.

Journal Name: Current Pharmaceutical Biotechnology

Volume 19 , Issue 9 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Vascular remodeling is an alteration in the structure of vessels in response to injury or hemodynamic changes. Disturbance of the structural and functional integrity of the endothelial cell layer can be observed in vascular remodeling associated with inflammation. Chemokines have been implicated in a wide range of diseases with prominent inflammatory components, and also in vascular remodeling. Among them, CC-chemokines are of great interest. They act through conventional CC-chemokine receptors (CCRs), widely expressed by leucocytes which are attracted to sites of chronic inflammation. However, many experimental data show that CCRs are expressed by vascular cells, suggesting a direct, leukocyte-independent effect on vascular remodeling.

Objective: Here, we discuss the role of CC-chemokines in atherosclerosis, angiogenesis, restenosis and renal dysfunction through direct activation of endothelial cells, endothelial progenitors, vascular smooth muscle cells, platelets, erythrocytes, mesangial cells and fibroblasts.

Results: The pathophysiological role of CC-chemokines has become more interesting since the discovery of the atypical chemokine receptor (ACKR) subfamily, that does not couple with G proteins and fails to transmit conventional intracellular signals. It has been demonstrated to be a chemokine scavenger or decoy receptor with a role in the regulation of acute inflammatory responses.

Conclusion: At the vascular level, ACKRs are expressed by endothelial cells and endothelial lymphatic cells that seem to regulate angio- and lymph-angiogenesis. Pleiotropic effects of CC-chemokines on vascular wall cells and leukocytes increase their importance in vascular remodeling and suggest new drugs to counteract vascular dysfunction.

Keywords: CC-chemokines, vascular remodeling, endothelial progenitor cells, adventitial fibroblasts, mesangial cells, platelets, vascular smooth muscle cells, atypical chemokine receptor (ACKR).

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 9
Year: 2018
Page: [715 - 727]
Pages: 13
DOI: 10.2174/1389201019666181017161447
Price: $58

Article Metrics

PDF: 25
HTML: 4